DIC: Which laboratory tests are most useful

被引:98
作者
Levi, Marcel [1 ]
Meijers, Joost C. [1 ]
机构
[1] Univ Amsterdam, Dept Vasc Med & Internal Med, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
关键词
Disseminated intravascular coagulation; Platelets; Coagulation factors; Coagulation inhibitors; Fibrin degradation products; Scoring systems; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR PATHWAY INHIBITOR; CRITICALLY-ILL PATIENTS; PROTEIN-C ACTIVATION; INTERNATIONAL SOCIETY; SOLUBLE FIBRIN; SCORING SYSTEM; SEVERE SEPSIS; PLASMINOGEN-ACTIVATOR; C4B-BINDING PROTEIN;
D O I
10.1016/j.blre.2010.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with disseminated intravascular coagulation (DIC) a variety of altered coagulation parameters may be detectable, such as thrombocytopenia, prolonged global coagulation times, reduced levels of coagulation inhibitors, or high levels of fibrin split products. In addition, more sophisticated tests for activation of individual factors or pathways of coagulation may point to specific involvement of these components in the pathogenesis of the disorder. There is not a single test, however, that is sufficiently accurate to establish or reject a diagnosis of DIC. Nevertheless, a combination of widely available tests may be helpful in making the diagnosis of DIC and can also be helpful to guide in the selection of DIC patients that require specific, often expensive, interventions in the coagulation system. More recently developed dynamic algorithms, assessing changes in coagulation parameters over sequential days, could further increase the diagnostic accuracy for DIC and may be helpful to detect early stages of coagulopathy potentially evolving into DIC. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 37
页数:5
相关论文
共 77 条
[1]   Time course of platelet counts in critically ill patients [J].
Akca, S ;
Haji-Michael, P ;
de Mendonça, A ;
Suter, P ;
Levi, M ;
Vincent, JL .
CRITICAL CARE MEDICINE, 2002, 30 (04) :753-756
[2]  
Anas AA, 2010, NETH J MED, V68, P147
[3]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[4]   Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation [J].
Bakhtiari, K ;
Meijers, JCM ;
de Jonge, E ;
Levi, M .
CRITICAL CARE MEDICINE, 2004, 32 (12) :2416-2421
[5]   THROMBOCYTOPENIA IN THE INTENSIVE-CARE UNIT [J].
BAUGHMAN, RP ;
LOWER, EE ;
FLESSA, HC ;
TOLLERUD, DJ .
CHEST, 1993, 104 (04) :1243-1247
[6]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[7]   Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response [J].
Bick, RL .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1996, 22 (01) :69-88
[8]   PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES [J].
BIEMOND, BJ ;
LEVI, M ;
TENCATE, H ;
VANDERPOLL, T ;
BULLER, HR ;
HACK, CE ;
TENCATE, JW .
CLINICAL SCIENCE, 1995, 88 (05) :587-594
[9]   ASSESSMENT OF HYPERCOAGULABLE STATES BY MEASUREMENT OF ACTIVATION FRAGMENTS AND PEPTIDES [J].
BOISCLAIR, MD ;
IRELAND, H ;
LANE, DA .
BLOOD REVIEWS, 1990, 4 (01) :25-40
[10]   LABORATORY METHODS FOR DETECTING DISSEMINATED INTRAVASCULAR COAGULATION (DIC) - NEW ASPECTS [J].
BREDBACKA, S ;
BLOMBACK, M ;
WIMAN, B ;
PELZER, H .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1993, 37 (02) :125-130